NIOX Group PLC (NIOX)

Industry Medical Devices
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

67.20p

Buy

69.20p

arrow-up1.00p (+1.48%)

Prices updated at 12 Dec 2025, 16:35 GMT
| Prices minimum 15 mins delay
|
Prices in GBX
Circassia Pharmaceuticals PLC is a biotechnology company. It is engaged in the development and commercialization of range of therapies for asthma and chronic obstructive pulmonary disease.
FTSE All-Share
arrow-down-0.48%
LSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
Sector
Healthcare
Industry
Medical Devices
Chairman
Mr. Ian Roy Johnson
CEO
Mr. Jonathan Charles Emms
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
84
Head office
1 Robert Robinson Avenue
Oxford
United Kingdom
OX4 4GA
mobile
+44 3303309356
letter
ir@circassia.com
computer
Company website

Key personnel

Owner name
chevron-l-regular
chevron-r-regular
Salary
Mr. Garry Watts MBE
Non-Executive Director, Senior Independent Director
-
Mr. Ian Roy Johnson
Non-Executive Director, Chairman
-
Mr. Nicholas Harwood Bertram Mills
Non-Executive Director
-
Mr. Robert Graham Naylor
Non-Executive Director
-
Mr. Jonathan Charles Emms
Executive Director, Chief Executive Officer
-

Top 5 shareholders

Owner name
chevron-l-regular
chevron-r-regular
No. of shares
Artemis Investment Management LLP8,469,652
Artemis UK Smaller Companies Fund8,469,652
JP Morgan Asset Management (UK) Ltd7,062,145
Danske Bank Asset Management6,636,354
Invesco Asset Management Ltd6,531,078

Director dealings

Date
chevron-l-regular
chevron-r-regular
Action
14 Jul 2025Purchase
25 Jun 2025Transfer in
20 May 2025Sale of Option
20 May 2025Exercise of Option
20 May 2025Exercise of Option
20 May 2025Exercise of Option
20 May 2025Sale of Option
11 Apr 2025Purchase
01 Apr 2025Transfer in
01 Apr 2025Transfer in
18 Dec 2024Sale
18 Dec 2024Purchase
18 Dec 2024Purchase
Please note that past performance is not a reliable indicator of future returns.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.